- Home
- SLXN vs ATCH Comparison
SLXN vs ATCH Comparison
Compare SLXN & ATCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLXN
- ATCH
- Stock Information
- Founded
- SLXN 2008
- ATCH 2022
- Country
- SLXN Israel
- ATCH United States
- Employees
- SLXN N/A
- ATCH N/A
- Industry
- SLXN
- ATCH
- Sector
- SLXN
- ATCH
- Exchange
- SLXN NYSE
- ATCH Nasdaq
- Market Cap
- SLXN 4.3M
- ATCH 4.4M
- IPO Year
- SLXN N/A
- ATCH N/A
- Fundamental
- Price
- SLXN $0.85
- ATCH $0.51
- Analyst Decision
- SLXN Strong Buy
- ATCH
- Analyst Count
- SLXN 1
- ATCH 0
- Target Price
- SLXN $5.00
- ATCH N/A
- AVG Volume (30 Days)
- SLXN 955.8K
- ATCH 2.1M
- Earning Date
- SLXN 05-21-2025
- ATCH 05-27-2025
- Dividend Yield
- SLXN N/A
- ATCH N/A
- EPS Growth
- SLXN N/A
- ATCH N/A
- EPS
- SLXN N/A
- ATCH 2.67
- Revenue
- SLXN N/A
- ATCH N/A
- Revenue This Year
- SLXN N/A
- ATCH N/A
- Revenue Next Year
- SLXN N/A
- ATCH N/A
- P/E Ratio
- SLXN N/A
- ATCH $0.21
- Revenue Growth
- SLXN N/A
- ATCH N/A
- 52 Week Low
- SLXN $0.21
- ATCH $0.49
- 52 Week High
- SLXN $13.56
- ATCH $99.00
- Technical
- Relative Strength Index (RSI)
- SLXN N/A
- ATCH 27.69
- Support Level
- SLXN N/A
- ATCH $0.49
- Resistance Level
- SLXN N/A
- ATCH $1.10
- Average True Range (ATR)
- SLXN 0.00
- ATCH 0.09
- MACD
- SLXN 0.00
- ATCH 0.08
- Stochastic Oscillator
- SLXN 0.00
- ATCH 3.29
About SLXN BIOMOTION SCIENCES
Silexion Therapeutics Corp is a developmental-stage company dedicated to the development of treatments for pancreatic cancer. The company is focused on enhancing its first-generation product (LODERTM ) to develop a newly formulated product to improve the clinical efficacy against pancreatic cancer.
About ATCH AtlasClear Holdings Inc. Common Stock
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and innovative financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.